Category Archives: Gadolinium

Featured Stories

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Omniscan NSF Lawsuit Settled

What would have been the first < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan lawsuit to go to a jury trial was settled at the last minute. The terms of the settlement are confidential, according to a report on ProPublica. Omniscan is gadolinium contrast dye that … Continue reading

Posted in Gadolinium, Pharmaceuticals |

First Omniscan Jury Trial Starts Today

The first jury trial involving General Electric’s < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye is scheduled to begin today. The plaintiff in the lawsuit, an elderly Minnesota woman, claims she developed nephrogenic systemic fibrosis (NSF) after being injected with Omniscan as part … Continue reading

Posted in Gadolinium, Pharmaceuticals |

Fewer Kidney Patients Received Gadolinium Agents Following 2006 NSF Alert

Fewer kidney patients have received < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dyes during MR studies since the US Food & Drug Administration (FDA) first issued warnings about their association with nephrogenic systemic fibrosis (NSF) in 2006. NSF is a condition involving the formation … Continue reading

Posted in Gadolinium, Pharmaceuticals |

FDA Strengthens Warnings on Gadolinium MRI Dyes

Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA for use with … Continue reading

Posted in Gadolinium, Pharmaceuticals |

Dutch Regulators Fault GE for Failing to Report Omniscan NSF Case

The Danish Medicines Agency has charged that GE Healthcare violated Dutch law when it failed to promptly and completely inform regulators about a patient who died after developing nephrogenic systemic fibrosis (NSF) following exposure to < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan contrast dye. According … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Healthcare Advised to Restrict Omniscan in 2006

GE Healthcare’s own experts recommended in May 2006 that it proactively restrict the use of < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan, a gadolinium contrast dye, after it was linked to nephrogenic systemic fibrosis (NSF). According to a ProPublica investigation, rather than take that advice, … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Drops Omniscan Libel Suit

GE Healthcare has dropped a libel suit it filed in the United Kingdom (UK) against a Danish researcher who had who warned its < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye was associated with nephrogenic systemic fibrosis (NSF) in 2007. When GE Healthcare sued … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Using UK Libel Laws to Shield Omniscan from Criticism, Doctor Claims

General Electric has been accused of trying to stifle criticism of its < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye by a Danish radiologist who warned it was associated with nephrogenic systemic fibrosis (NSF) in 2007. According to an article in The Guardian, … Continue reading

Posted in Gadolinium, Pharmaceuticals |

FDA Should Tighten Restrictions on Omniscan, OptiMark, Panel Says

A panel of medical experts reviewing gadolinium contrast dyes recommended last week that the labeling for General Electric’s Omniscan and Covidien’s OptiMark should have stronger warnings regarding their risk of < "http://www.yourlawyer.com/topics/overview/nsf">nephrogenic systemic fibrosis (NSF). According to an article on … Continue reading

Posted in Gadolinium, Pharmaceuticals |

First NSF Lawsuit to Go to Trial in California

One of the first trials involving a < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye – Magnevist – and nephrogenic systemic fibrosis (NSF) is set to begin in January. According to a report on Law.com, the outcome of the Magnevist trial could be a … Continue reading

Posted in Gadolinium, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.